It also allows the interventional cardiologist to fully grasp the salient patient characteristics

and particular clinical circumstances early in the process of this website care and directly from the initial provider, an interaction that can occur at night or during weekends while the receiving practitioner is away from the hospital where a fixed network would exist. This involvement may help to promote appropriate activation of the cath lab and to encourage efficient reperfusion for a STEMI. The potential advantage of having an experienced interventionalist engaged in the early stages of the triage process is supported by a study revealing that up to 1/3 of all patients transferred for primary PCI, encounter significant delays and inadequate DTB times. These delays are commonly due to diagnostic dilemmas and non-diagnostic electrocardiograms that may result in emergency department hold-ups [7]. 26s Proteasome structure An earlier involvement of an interventional cardiologist may reduce these diagnostic delays. Notably, when the different steps in the STEMI management process were evaluated, CHap impacted the STEMI management process by a reduction of the time from the initial call to the arrival at the interventional suite. It is conceivable that during this crucial step, specialized guidance could contribute to the resolution of diagnostic

dilemmas or uncertain electrocardiograms, as well as to expedite all parties for urgent patient transfer to the cath lab, which would translate in shorter DTB times and speedy reperfusions. Although portable defibrillators and monitors have the ability to transmit electrocardiograms effectively through a preconfigured network [12], a more manageable and inexpensive telecommunications Linifanib (ABT-869) system allows wider access at lower costs, while maintaining good reliability and performance. CHap brings substantial advantages

over fixed systems that are less mobile, require costly subscriptions, and use additional hardware. This easily accessible system may have important implications in the widespread adoption of this technology. Its availability to institutions with limited resources would particularly benefit, as these institutions usually do not have on-site PCI and participate in a larger referral network of care. In addition, early direct interaction with experienced interventional cardiologists has the potential to elevate the overall quality of care of ACS patients at both referral institutions and PCI centers. There are several limitations to this study. Although the enrollment was prospective and all-inclusive, the comparison groups were not randomized, which may result in strong selection bias. Also, the fact that it represents the experience of single center makes it subject to the known shortcomings of such evaluations.